Neuroendocrinology of mood disorders

Clinica Terapeutica

Volumn 155, Issue 11-12, 2004, Pages 537-541

  Mazza, Marianna ^a,b   Satta, M A ^a   Bria, P ^a   Mazza, S ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b NONE   (Italy)

Author keywords

Bipolar depression; Major depression; Mood disorders; Neuroendocrine system; Thyroid

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; GROWTH HORMONE; HYDROCORTISONE; PROLACTIN; PROTIRELIN; THYROTROPIN; VALPROIC ACID; VIGABATRIN;

BIPOLAR DISORDER; CLINICAL FEATURE; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC TEST; ENDOCRINE SYSTEM; HASHIMOTO DISEASE; HORMONE RESPONSE; HUMAN; HYPERTHYROIDISM; MAJOR DEPRESSION; MENTAL PATIENT; MOOD DISORDER; NEUROENDOCRINOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; QUALITY OF LIFE; REVIEW; SYMPTOMATOLOGY; WEIGHT GAIN; DEPRESSION; NEUROSECRETION; PATHOPHYSIOLOGY;

BIPOLAR DISORDER; DEPRESSIVE DISORDER; HUMANS; NEUROSECRETORY SYSTEMS;

EID: 20644452233     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Rasgon NL. Anatomic, functional, and clinical studies of neuroendocrine function in bipolar disorder. Adv Stud Med, 3 (8A): S726-732; 2003
2. Rush AJ, Giles DE, Schlesser MA, et al.: Dexamethasone response, thyrotropin releasing hormone stimulation, rapid eye movement latency, and subtypes of depression. Biol Psych, 41(9): 915-928, 1997
3. Schmider J, Lammers CH, Gotthardt U, et al.: Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression and in normal controls. Biol Psych, 38: 797-802, 1995
4. Linkowski P, Biauman H, Mendlewicz J: Thyrotropin response to thyrotropin-releasing hormone in unipolar and bipolar affective illness. J affect Disorders, 3: 9-16, 1981
5. Matsunaga H, Sarai M: Elevated serum LH and androgens in affective disorder related to the menstrual cycle with referrence to polycystic ovary syndrome. Jpn J Psychy Neurol, 47: 825-842, 1993
6. Sobczak S, Honig A, van Duinen MA, et al.: Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies. Bipolar Disorders, 4: 347-356, 2000
7. Sassi RB, Nicoletti M, Brambilla P, et al.: Decreased Pituitary volume in patients with bipolar disorder. Biol Psychiatry, 50: 271-280, 2001
8. O'Donovan C, Kusumakar V, Graves GR, et al.: Menstrual abnormalities in polycystic ovary syndrome in women taking valproate for bipolar mood disorder. J Clin Psych, 63: 322-330, 2002
9. Rasgon NL, Harden CL: Neuroendocrine dysfunction in women with epilepsy or bipolar disorder: implications for patient management. Adv Stud Med, 3(8A): S740-S744, 2003
10. Isojarvi JIT, Laatikainen TJ, Knip M, et al.: Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol, 39: 597-584, 1996
11. Bartalena L, Pellegrini L, Meschi M, et al.: Evaluation of thyroid function in patients with rapid-cycling and non-rapid-cycling bipolar disorder. Psych Research, 34: 13-17, 1990
12. Kusalic M: Grade II and grade III hypothyroidism in rapid-cycling bipolar patients. Neuropsychob, 25: 177-181, 1992
13. Post RM, Kramlinger KG, Joffe RT, et al: Rapid cycling bipolar affective disorder: lack of relation to hypothyroidism. Psych Research, 72: 1-7, 1997
14. Bauer MS, Whybrow PC: Rapid cycling bipolar affective disorder II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch Gen Psych, 47: 435-440, 1990
15. Gyulai L, Bauer M, Bauer MS, et al.: Thyroid hypofunction in patients with rapid-cycling bipolar disorder after lithium challenge. Biol Psych, 53: 899-905, 2003
16. Loosen PT: The TRH-induced TSH response in psychiatric patients: a possible neuroendocrine marker. Psychoneuroendocr, 10: 237-260, 1985
17. Duval F, Macher JP, Mokrani MC: Difference between evening and morning thyrotropin responses to protirelin in major depressive episode. Arch of Gen Psychiatry, 47: 443-448, 1990
18. Kirkegaard C, Faber J, Hummer L, et al.: Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression. Psychoneuroendocr, 4: 227-235, 1979
19. Joffe RT, Singer W, Levitt AJ et al.: A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psych, 50: 387-393, 1993
20. Siever LJ, Davis KL: Overview: toward a dysregulation hypothesis of depression. Am J Psych, 142: 1017-1031, 1985
21. Trestman RL, Yehuda R, Coccaro E et al.: Diurnal neuroendocrine and autonomic function in acute and remitted depressed male patients. Biol Psych, 37: 448-456, 1995
22. Mokrani MC, Bailey P, et al.: Thyroid axis activity and serotonin function in major depressive episode. Psychoneuroendocr, 24: 695-712, 1999
23. Mokrani MC, Duval F, Crocq MA, et al.: HPA axis dysfunction in depression: correlation with monoamine system abnormalities. Psychoneuroendocr 22 (Suppl 1), S63-S68, 1997
24. Dinan TG: Glucocorticoids and the genesis of depressive illness. A psychobiological model. Br J Psych, 164: 365-371, 1994
25. Esel E, Kartalci S, Tutus A, et al.: Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients. Progr in Neuropsychopharm and Biol Psych, 28: 303-309, 2004
26. Peteranderl C, Antonijevic IA, Steiger A, et al.: Nocturnal secretion of TSH and ACTH in male patients with depression and healthy controls. J Psych Research, 36: 189-196, 2002
27. Sullivan PF, Wilson DA, Mulder RT, et al.: The hypothalamic-pituitary- thyroid axis in major depression. Acta Psych Scandinavica, 95: 370-378, 1997
28. Engum A, Bjoro T, Mykletun A, et al.: An association between depression, anxiety and thyroid function: a clinical fact or an artefact? Acta Psych Scandinavica, 106: 27-34, 2002
29. Demet MM, Ozmen B, Deveci A, et al.: Depression and anxiety in hyperthyroidism. Arch Med Research, 33: 552-556, 2002
30. Cooke RG, Joffe RT, Levitt AJ: T3 augmentation of antidepressant treatment in T4-replaced thyroid patients. J Clin Psychiatry, 53: 16-18, 1992
31. Sawka AM, Gerstein HC, Marriott MJ: Does a combination regimen of Thyroxine (T4) and 3, 5, 3′-Triiodothyronine improve depressive symptoms better tha T4 alone in patients with Hypothyroidism? Results of a double-blind, randomised, controlled trial. J Clin End Metab, 88(10): 4551-4555, 2003
32. Degner D, Meller J, Bleich S, et al.: Affective disorders associated with autoimmune thyroiditis. J Neuropsych Clin Neurosci, 13: 4, 532-533, 2001
33. Marangell LB: Thyroid hormones and mood: are population data applicable to clinical cohorts? Acta Psychiatr Scandinavica, 106: 1-2, 2002